- OctoPlus is a Dutch listed company focused on the development of its proprietary drug formulation technologies, enhancing efficacy by applying liposomes and microspheres
- Main transaction rationale for Dr. Reddy’s is to get access to the knowledge and capabilities of OctoPlus
- Kempen & Co acted as financial adviser to Dr. Reddy’s
The investment services and investment institutions mentioned on the website may not be available in your jurisdiction or to anyone other than professional investors. More information about the countries where these investment institutions are registered and the persons to whom they may be offered can be found on the website.